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Purpose. The purpose of this practice improvement project was to increase cardiovascular 
disease (CVD) knowledge in women of color (WOC) in the primary care setting through 
enhanced provider to patient education through implementation of a provider toolbox. 
Background. CVD is the number one cause of death in women in the United States. However, 
WOC have a higher incidence of CVD than White women. Additionally, WOC have been found 
to have a decreased knowledge and awareness of CVD, demonstrated by numerous national 
studies. Therefore, the primary investigator (PI) identified a need to increase CVD knowledge 
and awareness in WOC in order to improve heart health outcomes in this patient population. 
Methods. An evidenced-based toolbox on CVD prevention in WOC for provider use was 
assembled by the PI. The toolbox was distributed to providers at Sea Mar Monroe clinic with an 
accompanying voiceover PowerPoint with instructions for intended use. A follow up mixed-
methods survey was sent to participants which aimed to evaluate the toolbox itself, its expected 
impact on patient outcomes and identify implications for future practice. Results. All 
participants (n=4) strongly agreed that the toolbox informed their knowledge on this clinical 
practice issue, strongly agreed that it will help them optimize cardiovascular health in WOC, and 
strongly agreed that it will facilitate evidenced-based practice. Half of the participants strongly 
agreed, and half agreed, that they felt better equipped to address this clinical practice issue after 
using the toolbox. Themes identified included time as a barrier for optimal CVD education for 
both patients and providers, conceptualizing race as a specific risk factor and lack of 
prioritization to take preventative action by WOC. Conclusion. WOC have a higher incidence of 
CVD paired with a decreased knowledge and understanding. Primary care providers are in a 
unique position to close this knowledge gap through patient education to reduce health 
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disparities in this population. This toolbox resource facilitated provider to patient CVD education 
in WOC.  























Cardiovascular disease (CVD) is the number one killer of women in the United States, 
claiming over 400,000 lives each year (American Heart Association, 2018). However, CVD 
affects women of color (WOC) more often than White women. The prevalence of CVD is 
approximately 48% in Black women, compared to 35% in Caucasian women (American Heart 
Association, 2018). Additionally, African American women have the highest age-adjusted 
mortality rate from CVD out of any female racial or ethnic group in the United States 
(Villablanca et al., 2010), and Hispanic women are more likely to have risk factors associated 
with CVD such as diabetes, overweight or obesity and physical inactivity (Giardina et al., 2013). 
In addition to having a higher rate of CVD compared to White women, women of color 
demonstrate decreased CVD knowledge and awareness (Reeder, 2017; Villablanca et al., 2016b). 
Knowledge and awareness of CVD may include heart disease as the leading cause of death in 
women, risk factors, preventative measures, signs and symptoms of a heart attack, and when and 
how to take emergency action. The American Heart Association (AHA) found that only 36% of 
Black women and 34% of Hispanic women identified heart disease as the leading cause of death 
in women, compared to 65% of White women in their national survey (2018). Therefore, the 
population with the highest risk for CVD possesses the least knowledge on what can be done to 
prevent the occurrence of disease. Additionally, physicians are more likely to falsely rate women 
at lower risk for CVD than men and underutilize preventative therapies (Bairey Merz, 2017; 
Wenger, 2012). Thus, there is a need to close this gap in heart health knowledge between women 
of color and White women in order to reduce further health disparity, hence the purpose of this 
project. 
Purpose & Aims 
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The purpose of this project is to increase CVD knowledge and awareness in WOC in the 
primary care setting through enhanced provider to patient education. The first aim was to 
assemble a toolbox containing evidenced-based resources that would guide healthcare providers 
in both patient education and the cardiovascular care of WOC. The second aim was to present 
the toolbox to healthcare providers at the clinic and engage with them to utilize the toolbox as a 
resource to facilitate preventative strategies with WOC. The third aim was to inform healthcare 
providers on WOC’s decreased CVD knowledge and awareness so that they would take special 
care to educate this patient population.  
Background & Significance  
Previous Efforts to Raising Awareness 
CVD is a largely misunderstood disease by many. The false belief that CVD is 
predominately a man’s disease still persists in society in present day (Galbraith, Mehta, Veledar, 
Vaccarino, & Wenger, 2011). These misunderstandings encourage women to shy away from 
protecting themselves from CVD because they do not personally think they are at risk. 
Unfortunately, the literature reveals that even physicians are more likely to falsely rate women at 
lower risk for CVD than men (Bairey Merz, 2017; Villablanca et al., 2010; Wenger, 2012). The 
truth is that CVD impacts one in four women in the United States and is the leading cause of 
death in both men and women (Reeder, 2017). Therefore, CVD is a substantial threat to women’s 
health that many people, even doctors, underestimate. Awareness of CVD as the leading cause of 
death in women has been positively associated with healthy lifestyle modifications and 
preventive action in women (Christian et al., 2007). Efforts to increase knowledge and awareness 
are necessary to encourage healthy behaviors in American women. 
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         Historically, efforts have been made by the American Heart Association to increase CVD 
knowledge and awareness among American women over the last two decades. These campaigns 
have been largely successful, nearly doubling awareness since 1997 (Villablanca et al., 2010). 
While CVD knowledge and awareness have increased in White women over that time period, 
gains have stagnated in WOC (AHA, 2018; Christian et al., 2007). This lack of knowledge and 
awareness is therefore creating further health disparities. 
Low Awareness in WOC 
         Present literature reveals that WOC have decreased knowledge and awareness of CVD 
compared to White women (AHA, 2018). The majority remain unaware that CVD is a potential 
threat to their wellbeing and, therefore, may not understand the importance of taking 
preventative measures even after many awareness-raising campaigns. Knowledge and awareness 
were found to be significantly lower in all groups of WOC, including Black, Hispanic and 
American Indian women, compared to White women in a survey by Villablanca, Slee, Lianov, & 
Tancredi (2016b). Data from another survey found that Black and Hispanic women were 66% 
less likely than White women to correctly identify heart disease as the number one killer of 
women as a whole, and that difference did not differ substantially between those two groups 
(Mochari-Greenberger, Miller, & Mosca, 2012). Christian et al. (2007) concluded that awareness 
was significantly lower in Black and Hispanic women than White women. The same survey 
reported that Hispanic women were more likely to state that “there is nothing they can do to 
prevent their risk of heart disease”. Asian women were also identified to have less CVD 
knowledge and felt the least motivated to change their modifiable risk factors in a study 
conducted by Galbraith et al. (2011). Overall, knowledge, awareness and how to take 
preventative measures is cited as lowest in groups of WOC throughout the relevant literature.   
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Highest Risk and Lowest Awareness 
         There is a high level of disparity among groups of WOC in regard to CVD prevalence, 
morbidity and mortality. The literature demonstrates that knowledge and awareness is the lowest 
in groups of women who have the highest risk of CVD, specifically WOC (Flink, Sciacca, Bier, 
Rodriguez & Giardina, 2013). Out of all women in the United States, Black women have the 
highest prevalence and death rate from CVD (AHA, 2018). African American women suffer 
from the highest rates of hypertension and obesity, contributing to an increased risk of CVD 
(Villablanca et al., 2016a). Reeder (2017) found that the majority of African American women 
do not personally believe that they are personally at risk for CVD, according to the survey 
conducted in the study. Additionally, Hispanic women suffer from diabetes, hypertension and 
obesity at higher rates than White women, also putting them at a higher risk for developing CVD 
(Giardina et al., 2013). Both a high Framingham Risk Score, which measures CVD risk, and a 
diagnosis of metabolic syndrome were inversely related to CVD knowledge and awareness in a 
study by Flink et al. (2013). Giardina et al. (2013) established that Hispanic women who were 
overweight or obese also demonstrated decreased knowledge and awareness scores compared to 
those who were normal weight. According to these findings, CVD prevention strategies are 
needed in high-risk women who have the least knowledge and awareness. 
Interventions for WOC 
The majority of literature on the topic of WOC and CVD awareness is limited to non-
experimental surveys. Few studies implement an experimental intervention that examines how 
educating WOC on CVD impacts overall health. However, researchers in a study by Villablanca 
et al. (2016a) implemented a four-month long heart health program in a cohort of African 
American women. The findings revealed a significant knowledge gain plus a significant 
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reduction in clinical risk factors such as waist circumference, serum cholesterol levels and 
inflammatory biomarkers. Participants also demonstrated a 60% decrease in metabolic syndrome 
in the cohort of women studied. In another study, Villablanca et al. (2010) researchers 
implemented a six-month long program that involved education, health behavior counseling and 
risk reduction strategies in a group of women who were clinically at high risk for CVD. This 
intervention showed a significant increase in knowledge and awareness. Additionally, there was 
a general decrease in systolic blood pressure and LDL cholesterol with an increase in HDL 
cholesterol among participants. 
         In conclusion, the present literature reveals that WOC, who have the highest risk for 
CVD, have the least knowledge and awareness. Therefore, efforts to educate WOC on CVD 
prevention and provide them with strategies to reduce their risk is an area of practice that can be 
improved upon, and advanced practice providers and physicians are well-suited to help close this 
knowledge gap in patients who are WOC. 
Theoretical Framework 
The theoretical framework used for this project was the Promoting Action on Research 
Implementation in Health Services (PARIHS) Model. This framework focuses on the 
implementation of research into practice through the interplay of three core elements: evidence, 
context and facilitation (Rycroft-Malone, 2004). It served as a guide for the implementation 
elements needed for successful adoption of the toolbox by the providers. Evidence refers to 
knowledge from a variety of sources found to be credible. The element of evidence corresponds 
to the assembly of a toolbox containing evidenced-based resources. Context refers to the 
environment or setting in which people receive health services and the setting in which research 
evidence is brought into practice. The element of context refers to the primary care clinic in 
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which the toolbox will be implemented. The last element, facilitation, refers to the process of 
enabling the implementation of evidence into practice. It also refers to leadership within the 
organization and readiness for implementation of the project. This corresponds with the project 
aim of bringing the research into practice through a convenient and user-friendly toolbox.  
Methods 
Design 
This project was a practice improvement project with a summative survey evaluation. 
The purpose of this project was to increase cardiovascular disease (CVD) knowledge and 
awareness in women of color (WOC) in the primary care setting through enhanced provider to 
patient education. The first aim was to assemble a toolbox containing evidenced-based resources 
that will guide healthcare providers in both patient education and the cardiovascular care of 
WOC. The second aim was to present the toolbox to healthcare providers at a primary care clinic 
and engage them to utilize the toolbox as a resource to facilitate preventative strategies with 
WOC. The third aim was to inform healthcare providers on WOC’s decreased CVD knowledge 
and awareness so that they may better educate this patient population. The toolbox is a means of 
disseminating information to providers in order to improve clinical practice and the health 
outcomes of this patient population. The utility of the toolbox, its expected impact on patient 
outcomes, provider knowledge after viewing the toolbox and presentation and implications for 
future practice were evaluated through an online survey. This project was submitted to Seattle 
University’s Institutional Review Board (IRB) and determined not to be human subjects research 
and, therefore, exempt from further review. 
Setting 
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The setting of this practice improvement project was Sea Mar Community Health 
Center’s Monroe location located in Monroe, Washington in Snohomish County. However, all 
interaction with participants and all project processes were conducted virtually over Zoom or 
email due to the COVID-19 pandemic and social distancing guidelines. The Monroe clinic serves 
a diverse population of patients. Majority of the patients at Sea Mar Monroe are low income 
earners and are underinsured or uninsured, and 80% are Latino and Spanish speaking. 
Recruitment Plan & Participants 
Inclusion criteria for participation was providers at the clinic (including physicians, 
advanced registered nurse practitioners [ARNPs], physician assistants [PAs] or registered nurses 
[RNs]) and relevant clinic personnel including health educators, care coordinators or 
nutritionists. Exclusion criteria was medical assistants (MAs) and other support or office staff. 
The site preceptor, an ARNP working at the clinic, identified the participants who met inclusion 
criteria. One ARNP, four physicians, a health educator and a chronic care coordinator met 
inclusion criteria. They were recruited via email by the primary investigator (PI). Participation 
was defined as reviewing the toolbox, using it as a clinical resource in practice as appropriate 
and participating in a follow up survey. Participation in this project was voluntary. 
Intervention and Data Collection Procedures 
The toolbox was assembled and formatted into a PDF document by the PI (See Appendix 
A). The toolbox’s contents include general information on CVD, current practice guidelines, 
local and national health indicators and statistics, patient education topics and resources, and 
cultural considerations. The toolbox was distributed as an attachment to participants via email. 
The body of the email contained a letter to participants that introduced the project and its 
intention. A project timeline was also given. An accompanying voiceover PowerPoint 
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presentation was also provided which gave further background on the project and instruction on 
the toolbox’s intended use. The rationale for a voiceover PowerPoint was so that participants 
would be able to view the presentation on their own time, facilitating convenience and 
accommodating varying work schedules. The presentation encouraged participants to utilize the 
toolbox resource in clinical practice. Six weeks later, a link to a Qualtrics survey was emailed to 
participants. The aim of the survey questions was to evaluate the participant’s awareness of this 
clinical practice issue, participant's assessment of the utility of the toolbox, its expected impact 
on patient outcomes and identify implications for future practice. When participants clicked on 
the link to the survey, there was an informed consent statement before the first question. Consent 
was obtained by participants proceeding to the first question. Participants were encouraged to 
complete the survey within two weeks with a reminder email sent one week in between. 
However, due to low response rate, the PI sent an additional reminder via email four weeks after 
the survey was initially distributed. The survey responses were kept anonymous. The PI analyzed 
the survey results and formatted them into an executive summary that included both a written 
explanation of the results and bar graphs depicting specific quantitative data. It was then 
distributed to the participants via email (See Appendix B). 
Measures and Instruments 
The survey used in this project was a mixed methods survey because it included both 
five-point Likert scale questions and free response questions (see Appendix C). The Likert scale 
is a widely used instrument that assesses attitude by allowing participants to rate how much they 
agree or disagree with a given statement. It assumes that the strength of an attitude is linear and 
that attitudes can be measured in a quantifiable way (McLeod, 2019). There were four questions, 
written as statements, and participants rated their attitudes on a five-point scale from strongly 
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agree, somewhat agree, neither agree nor disagree, somewhat disagree and strongly disagree. 
Reliability was increased by using a five-point Likert scale for survey responses as opposed to 
three- or four-point scales (McKelvie, 1978). There were five free response questions. Free 
response questions are intended to elicit respondent comments, opinions, recommendations or 
suggestions. Social desirability has been shown to reduce the validity of surveys, therefore, 
keeping the survey responses anonymous was an effort to increase the validity of this evaluation 
(McLeod, 2019). 
Data Analysis 
Data for analysis was obtained through the mixed methods Qualtrics survey described 
above. The quantitative data was analyzed individually as a Likert-type item, rather than as a 
composite scale which is done in traditional Likert-scales (Boone & Boone, 2012). The reason 
for this is because the survey questions aimed to assess varying topics surrounding the toolbox, 
so it would not have been logical to interpret them as a composite score. Data from the Likert-
type is ordinal, and therefore, underwent descriptive statistics using Microsoft Excel. 
Frequencies were counted and the median and mode were determined to assess central tendency 
of responses. The qualitative data obtained from the free response questions underwent content 
analysis for themes using Microsoft Word. Themes were grouped into broad, overarching 
categories and then compared and contrasted. The frequencies were depicted in bar graph format. 
Median and mode were also calculated and described. The qualitative data was summarized in 
paragraph format. 
Results 
 The participant survey had a 50% response rate (n=4). Overall, participants evaluated the 
toolbox resource itself favorably. The quantitative data from the Likert-type items and fill in the 
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blank item is described below with accompanying bar graphs indicating the frequency of 
responses. The qualitative data from the free response questions is summarized below, organized 
by each question.  
Quantitative Data 
Fill in the Blank Item. Participants were asked to estimate how many WOC patients 
they see on a weekly basis for CVD (question 1). The mean was 15.3 patients according to 
participants who answered this question (n=3). The median was 8 patients.  
Likert-Type Items. All participants (n=4) strongly agreed that the toolbox informed their 
knowledge on WOC and CVD (see Figure 1). Half of the participants strongly agreed that they 
felt better equipped to address this clinical practice issue after viewing the toolbox and its 
presentation, and the other half of participants somewhat agreed (see Figure 2). All participants 
strongly agreed that the toolbox would enable them to optimize cardiovascular care of WOC at 
risk for CVD (see Figure 3). All participants strongly agreed that the toolbox resource will help 
them facilitate evidence-based practice in their practice setting (see Figure 4).  
The median and mode were analyzed to determine central tendency of responses. The 
scale for the responses ranged from numbers 1 through 5, with 1= strongly disagree and 5= 
strongly agree. Based on this information, it can be determined that the central tendency of 
responses was consistent with “strongly agree” for all questions except question three, which 






















Note. “I anticipate that the toolbox resources will help me to facilitate evidence-based practice in 
my practice setting.” 
 
Table 1 
Median and Mode of Likert-Type Item Responses 
Variable Median Mode 
   
Question 2 5 5 
Question 3 4.5 4, 5 
Question 4 5 5 
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Question 5 5 5 
 
Qualitative Data 
Of the four participants who responded to the survey, only three participants completed 
the free response questions (n=3). There was a total of four free response questions that 
underwent content analysis for themes. The common themes identified were conceptualizing 
race as a specific risk factor, time as a barrier for both providers and WOC, and money and lack 
of prioritization as barriers for WOC. In addition to common themes, other findings are 
described below due to the small sample size. 
How has this toolbox impacted your approach to care of patients who are women of 
color at risk for cardiovascular disease? Please explain. The common theme identified in the 
analysis of the above question was specific risk factors for groups of WOC. One participant 
stated, “I think it becomes second nature to always approach every patient in an algorithmic way, 
and sometimes we forget that there are all these other variables such as race.” Another 
participant reported that the toolbox has “made it easier for patients to understand how at risk 
they are” according to their race or ethnicity. 
How do you expect that provider use of this toolbox will impact patient outcomes? 
Please explain. Answers to the above question varied by participant, therefore, no common 
themes were identified. However, one participant addressed visualization as a way to help 
patients better understand medical concepts. Another participant reported that the toolbox gave 
them a better understanding of this clinical practice issue and how to approach it.  
What barriers do you believe providers face in providing CVD education to 
patients? Please explain. Time was the common theme across all participant responses. One 
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participant reported fifteen-minute appointment times are a barrier to executing the best care, 
including education, and another reported that there is not enough time allotted to cover 
everything in detail in a single patient visit.  
What barriers do you believe patients who are women of color face in taking action 
to prevent their risk of CVD? Please explain. Both time and money were identified as a major 
barrier to WOC seeking preventative care or following up on appointments. Participants 
expressed that financial barriers decrease patient willingness to seek out preventative care. 
Another theme was family prioritization. Participants described WOC patients as mothers, 
spouses and full-time workers, making them more likely to put their own health “on the back 
burner” and prioritize family needs above their own. Additionally, one participant identified lack 
of understanding and a need for repeat education as a barrier.  
Discussion 
 Overall, this practice improvement project was evaluated favorably by participants 
through a summative survey evaluation. The survey questions aimed to evaluate changes in 
provider knowledge of this clinical practice issue after using the toolbox and viewing its 
presentation, the utility of the toolbox, its expected impact on patient outcomes and identify 
implications for future practice.  
Limitations 
 A primary limitation of this project was the limited number of participants. Sea Mar 
Monroe is a small clinic and only eight participants were identified as eligible and, therefore, 
invited to use the toolbox and participate in the follow up survey. Retrospectively, it may have 
been useful to ask participants whether or not they actually used the toolbox. However, based on 
the number or participants who responded to the survey, it is likely that only four of the eight 
 21 
total participants used the toolbox. For this reason, data for analysis was limited for both the 
Likert-type items (n=4) and fill in the blank and free response questions (n=3). However, 
participant’s responses were mostly consistent, giving the data some degree of meaningfulness.  
Another limitation was participant engagement. Engaging with participants was 
challenging due to the COVID-19 pandemic. The PI was limited to email as a means of 
communicating with participants and it can be inferred that face-to-face communication would 
have boosted participation and enthusiasm. However, this was not possible due to social 
distancing guidelines at the time of implementation. Additionally, the site preceptor indicated 
that it was challenging for participants to find extra time to review project materials due to 
increased workload and demands of the clinic associated with the pandemic.  
Implications for Future Practice 
The information and resources in the toolbox served as a useful resource in both 
increasing provider awareness of this health disparity and educating WOC patients on CVD as 
indicated in the survey results. In the long term, it is predicted that participant use of this toolbox 
will improve health outcomes in this patient population if toolbox use is continued. Participants 
should note that practice guidelines may be updated in the future and will need to make changes 
accordingly if they wish to continue toolbox use. 
Time is found to be a barrier for both providers and patients. Providers express difficulty 
providing in-depth education on CVD prevention due to short appointment times, and providers 
report that patients are often unable or unwilling to take the time for preventative care and follow 
up. A potential solution to this dilemma would be to include alternate forms of CVD education in 
addition to typical provider-to-patient verbal education. Providers at Sea Mar Monroe may use 
EPIC’s patient education materials on CVD and attach it to the after-visit summary. This has the 
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potential to increase patient education in a manner that is time-sparing for both patients and 
providers. Additionally, providers may take advantage of referring WOC at risk for CVD to the 
clinic health educator or dietician for further counseling.  
Additionally, this toolbox has the potential to be used in other practice settings where 
primary and preventative care is delivered. With the exception of health indicators specific to 
Snohomish County and Washington state, the toolbox is generalizable to a national audience. 
Local statistics may be updated or removed if it were to be used in a different geographical 
location. Additionally, Sea Mar Monroe may wish to distribute this toolbox to their other clinic 
locations throughout Washington State.  
Conclusion 
 Disparities in both CVD risk and CVD knowledge and awareness exist among women of 
color in the United States. Primary care providers are in a position to ameliorate these disparities 
by providing patient education on this topic and partnering with patients on risk reduction 
strategies. This practice improvement project demonstrated that a provider toolbox of CVD in 
WOC was beneficial in raising both provider and patient knowledge and awareness of this topic 
in the primary care setting. In future practice, providers should take care to deliver patient 
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THE PROBLEM: Women of Color have an increased risk of 
cardiovascular disease (CVD) paired with a decreased knowledge and 
understanding of CVD. 
 
§ CVD is the #1 killer of American women. (AHA, 2018) 
§ The prevalence of CVD in White women is 35%, compared to 48% in women of 
color. (AHA, 2018) 
§ African American women have the highest mortality rate from CVD out of any 
female racial or ethnic group in the U.S. (CDC, n.d.; Villablanca et al., 2010) 
§ Hispanic women are more likely to have risk factors associated with CVD such 
as diabetes and obesity (Giardina et al., 2013) 
§ South Asian persons have an increased risk of morbidity and mortality from 
ischemic heart disease and have not benefitted from the same decline in cases as 
the general population over the last few decades (Graham, 2015). 
§ Only 36% of Black women and 34% of Hispanic women were able to 
identify CVD as women’s number one cause of death, compared to 65% of 
White women in a national survey by the American Heart Association. Read 
more about the study HERE  
§ Decreased knowledge and awareness have been associated with decreased 
strategy to take preventative action against CVD (Christian et al., 2007).  
§ Physicians are more likely to falsely rate women at lower risk for CVD than men, 
underutilizing preventative strategies (Bairey Merz, 2017; Wenger, 2012)  
 
THE PURPORSE of this toolbox is 
to 1) Raise provider awareness on 
the disparities that exist in CVD risk 
and knowledge in women of color 
and 2) Equip providers with a 
resource to facilitate preventative 
strategies with patients who are 




CVD is an umbrella term that includes numerous manifestations of cardiac and vascular 
disease. There are four diagnostic categories of CVD: 
1. Coronary Heart Disease (e.g. MI, Angina Pectoris) 
2. Cerebrovascular Disease (e.g. Stroke, TIA) 
3. Peripheral Arterial Disease 
4. Aortic Atherosclerosis or Aneurysm 
 
Healthy People 2020 has two main objectives 
related to CVD: 1) To increase the overall 
cardiovascular health in the U.S. and 2) To 
reduce the number of coronary heart disease 
deaths (baseline: 129.2 deaths per 100,000 




Risk Factors for CVD can be divided into modifiable and nonmodifiable. 
 
Modifiable risk factors are estimated to be the cause of more than one half of the 




§ Overweight and Obesity 
§ Physical Inactivity 
§ Unhealthy Diet 
§ Smoking or Tobacco Use 
§ Metabolic Syndrome 
 
Nonmodifiable Risk Factors 
§ Family History of CVD, especially premature CVD—age <55 males/<65 females 
§ Age >65 (compared to >55 in males) 
§ High Risk Race or Ethnicity 
§ Low Socioeconomic Status 
§ Poor Access to Healthcare and Preventative Services 
§ CKD 
§ Chronic Inflammatory Conditions 
 
Risk Factors Unique to Women (ACOG, 2016; Douglas & Poppas, 2019). 
§ Early Menarche 
§ Use of Combined Oral Contraceptives (COCs)— Although generally safe, they 
are associated with an increased risk of heart attack or stroke in women with 
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multiple risk factors for or known atherosclerotic cardiovascular disease 
(ASCVD). 
§ Polycystic Ovarian Syndrome (PCOS) 
§ Pregnancy Complications, including gestational hypertension or preeclampsia 
and gestational diabetes 
§ Postmenopausal State and Early Menopause (age <40) 
o Menopause transition is associated with increased risk (Heart, 2010) 
o It is notable that hormone replacement therapy (HRT) was not 
demonstrated to be cardioprotective in the WHI and HERS trials 
§ HRT—combined hormone therapy presents a small increase in risk of heart 
attack and stroke  
§ Autoimmune Disorders—lupus and rheumatoid arthritis are more common in 
women and are associated with increased risk of CVD 
§ Lipoproteins—low HDL, rather than high LDL, is more predicative of risk in 
women 
 
Risk Factors by Race & Ethnicity 
 
Disease Risk and Risk Factors Amongst Different Ethnic and Racial Groups (Graham, 2015). 






Men vs. Women 
The risk of CVD is often underestimated in women by both patients and providers. 
Under-recognition and variable clinical presentation are related to less aggressive 
treatment strategies. Women, especially women of color, are also underrepresented in 
clinical trials (Heart, 2010). Additionally, physicians are less likely to discuss risk and 
provide preventative care to women than men (American College of Cardiology, 2019).  
 
Men and women may experience different anginal symptoms. Therefore, it is crucial to 
educate patients on this matter so that they can identify signs and symptoms of a heart 
attack and when to take emergency action. While chest pain is the most common anginal 
symptom in both men and women, women are more likely to experience other symptoms 
including nausea, shortness of breath, back or jaw pain, or lightheadedness.  
 
Women of Color 
Overall, people of color have an increased risk of morbidity and mortality due to CVD 
and have not benefited to the same extent from the general decline in heart disease 
related deaths in the U.S. over the last few decades (Graham, 2015). Women of color 
demonstrate a higher mortality rate from CVD than White women. In particular, 
African American women have a higher death rate from CVD compared to White 
females and mortality is more likely to occur at a younger age (CDC, n.d.; Graham, 2015). Black 
and Hispanic women have the highest rates of obesity, hypertension and diabetes in the 
U.S., contributing to increased risk. 
 
There also exists a knowledge gap in women of color on awareness of heart disease as 
women’s number one health threat (American Heart Association, 2018; Reeder, 2017; Villablanca et al., 2016). 
This is significant because decreased knowledge and awareness have been associated 




Heart disease, which is responsible for 22.3% of deaths in women nationally, is the 
leading cause of death in women in the United States and coronary artery disease is the 
most common form (CDC, 2020). Black women in the United States exhibit the highest rates 
of both hospitalization and death from CVD nationwide (CDC, n.d.; CDC, 2020). 
 
National CVD Hospitalization Rate per 1,000 Medicare Beneficiaries, Women Age 
65+, 2015-2017 








National CVD Death rate per 100,000, Women, All Ages, 2016-2018 
All Races/Ethnicities 179.6 
American Indian/Alaskan Native 158.9 
Asian and Pacific Islander 108 
Non-Hispanic Black 238.6 
Hispanic 131.4 
Non-Hispanic White 180.8 
(CDC, n.d.) 
 
Check out the CDC’s Interactive Atlas of Heart Disease and Stroke to compare CVD 
hospitalization and death rates by race/ethnicity, gender and geographical location. 
 
Local 
In Washington State, CVD is the second leading cause of death in women after cancer, 
compared to the leading cause nationally (Washington State Department of Health, 2017). In Washington 
state, Black women have the highest hospitalization rate. However, American Indian and 
Alaskan Native women have the highest death rate, followed by Black women and then 
White women. Hispanic women have a higher hospitalization rate than White women, 
however, their death rate is lower. 
 
Washington State CVD Hospitalization Rate per 1,000 Medicare Beneficiaries, 
Women Age 65+, 2015-2017* 





*National Rate: 53.3 
 
Washington State CVD Death rate per 100,000, Women, All Ages, 2016-2018* 
All Races/Ethnicities 152 
American Indian/Alaskan Native 195.6 
Asian and Pacific Islander 104.1 
Non-Hispanic Black 187 
Hispanic 111.1 
Non-Hispanic White 155.8 
(CDC, n.d.) 
*National Rate: 179.6 
 
In Snohomish County, CVD is also the second leading cause of death after cancer 
(Washington State Department of Health, 2017).  Black women are disproportionately affected by CVD. 
Hospitalizations in Black women are above both the state and national rate and deaths in 
Black women are above the state rate. Additionally, American Indian and Alaskan 









Snohomish County CVD Hospitalization rate per 1,000 Medicare beneficiaries, 
Women, Age 65+ 2015-2017* 
All Races/Ethnicities 42.3 
Non-Hispanic Black 60.3 
Non-Hispanic White 43.3 
Hispanic Insufficient data 
(CDC, n.d.) 
*National Rate: 53.3, State Rate: 42.2 
 
Snohomish County CVD Death rate per 100,000, Women, All Ages, 2016-2018* 
All Races/Ethnicities 145.1 
American Indian/Alaskan Native 188.7 
Asian and Pacific Islander 91.9 
Non-Hispanic Black 173.7 
Hispanic 95.8 
Non-Hispanic White 149.6 
(CDC, n.d.) 






















Top 10 Takeaways from the 2019 ACC/AHA Guidelines on the 
Primary Prevention of Cardiovascular Disease: 
 
1. The most important way to prevent ASCVD, heart failure and atrial fibrillation is 





















































ABCDE of Primary Prevention: Lifestyle Changes and Team-
Based Care 
 
The ABCs of Primary Cardiovascular Prevention: 2019 Update.  
(Alfaddagh, Arps, Blumenthal & Martin, 2019) 
  
Aspirin 
Aspirin is no longer recommended as pharmacologic treatment for the primary 
prevention of ASCVD due to lack of net benefit. However, it is still recommended as 
secondary prevention. Primary prevention with low-dose aspirin may be considered in 
select patients who have high-risk for ASCVD* and are not an increased risk for 
bleeding (Rubenfire, 2019). 
 






ACC/AHA 2017 Classification for Hypertension: (Rubenfire, 2019). 
Blood Pressure Systolic Diastolic 
Normal <120 <80 
Elevated 120-129 <80 
Stage 1 130-139 80-89 
Stage 2 ≥140 ≥90  
 
ACC/AHA 2017 vs. JNC 8: When to Start Pharmacotherapy 
ACC/AHA  JNC 8  
Patients w/o CVD and 
10-year risk <10% 
At 140/90 Patients ages <60 At 140/90 
Patients w/ CVD or 10-
year risk >/=10% 
At 130/80 Patients ages 60+ At 150/90 
Patients ages 65+ SBP ≥130 Patients w/ 
diabetes 
At 140/90 
Patients w/ Diabetes At 130/80 Patients w/ CKD At 140/90 
Patients w/ CKD At 130/80   
 
 
ACC/AHA 2017 vs. JNC 8: Blood Pressure Goals in Patients with Hypertension 
ACC/AHA*  JNC 8  
Most Patients <130/80 Patients ages <60 <140/90 
Patients ages 65+** SBP <130 Patients ages 
60+*** 
<150/90 
Post stroke or TIA w/o 
previously treated HTN 
<130/80 Patients w/ Diabetes <140/90 
Post stroke or TIA w/ 
previously treated HTN 
<140/90 Patients w/ CKD <140/90 
(Hernandez-Villa, 2015; Ripley & Barbato, 2018) 
 
*Lower goals influenced by the results of the SPRINT Trial. 
**Consider risk for falls, dementia or Parkinson’s, orthostasis, other comorbidities and 
limited life expectancy. 




According to both the ACC/AHA and JNC 8 guidelines, race should be considered when 
initiating pharmacologic therapy, specifically in Black patients.  
 
The ACC/AHA recommends the use of thiazide diuretics or calcium-channel 
blockers as first line treatment in the management of hypertension in Black patients, 
including those with diabetes. (Carey, Whelton, & 2017 ACC/AHA Hypertension Guideline Writing Committee, 




The JNC 8 also recommends the use of a thiazide diuretic or a calcium-channel 
blocker for the initial treatment of hypertension in the Black population (general Black 
population- moderate, grade B recommendation; Black with diabetes- weak, grade C 
recommendation). These findings are based on results from the ALLHAT trial which 
demonstrated better cardiovascular outcomes in Black patients than when using ACE-
Inhibitors. ACE-Inhibitors were also found to be less effective in lowering blood 
pressure as opposed to calcium-channel blockers in the black population. (James et al., 2014). 
 
Cholesterol: ASCVD Risk & Statin Recommendations 
 
ASCVD Risk Calculator  
Risk calculators provide a frame of reference for risk in patients without ASCVD using 
population-based and clinical trial outcomes with the goal of matching need for and 
intensity of preventative therapies to absolute risk of an ASCVD event in the next 10 
years (ACC/AHA, 2019). It is recommended that patients ages 20 and older without established 





However, it is essential that providers recognize that risk calculators do not consider all 
risk factors contributing to higher risk, such as low socioeconomic status  
(SES), race and risk factors unique to women. In fact, the risk calculator is best 
validated among non-Hispanic Whites and non-Hispanic Blacks. This may inaccurately 
assess risk in patients of other races and ethnicities who are known to be at greater risk, 
including Latinx and South Asian ancestry (Rubenfire, 2019).  
 
Additional Considerations from the ACC/AHA 2019 Guidelines on the Primary 
Prevention of CVD: (ACC/AHA, 2019) 
§ No single risk calculator is effective for all patients 
§ Risk may be underestimated in patients with chronic inflammatory conditions 
(e.g. autoimmune conditions) or HIV/AIDS and low SES. Patients with familial 
hypercholesterolemia are also at increased risk not captured in risk calculators.  
§ Risk may be overestimated in patients with higher SES and those with continual 
access to care and preventative services. 
§ Thus, in patients who score borderline (5% to <7.5%) or intermediate (>/=7.5% 
to <20%), additional risk-enhancing clinical factors should be considered: 
o Family History of Premature ASCVD 
o Primary Hypercholesterolemia 
o Metabolic Syndrome 
o Chronic Kidney Disease 
o Chronic Inflammatory Conditions 
o Conditions Specific to Women 
§ Early menarche, early menopause, pregnancy complications, 
PCOS, HRT 
o High Risk Race/Ethnicity 
o Lipids & Biomarkers Associated with Increased ASCVD Risk: 
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§ Persistent hypertriglyceridemia (≥ 175) 
§ Elevated High-Sensitivity C-Reactive Protein (≥2 mg/dL) 
§ Elevated Lp(a) levels (≥50 mg/dL or ≥125 nmol/L) 
§ Elevated ApoB levels ≥ 130 mg/dL 
§ ABI >0.9 
 
Statin Recommendations 
From the 2019 ACC/AHA Guideline on the Primary Prevention of CVD: (Rubenfire, 2019) 
§ Patients ages 20-75 years and LDL-C ≥190 mg/dl: Use a high-intensity statin 
without risk assessment. 
§ Patients ages 40-75 and Type 2 Diabetes: Use a moderate-intensity statin and 
risk estimation to consider a high-intensity statin. Risk-enhancers in diabetics 
include ≥10 years for T2DM and 20 years for type 1 DM, ≥30 mcg albumin/mg 
creatinine, eGFR <60 ml/min/1.73 m2, retinopathy, neuropathy, ABI <0.9. In 
those with multiple ASCVD risk factors, consider high-intensity statin with aim 
of lowering LDL-C by 50% or more. 
§ Patients ages >75 years: Clinical assessment and risk discussion. 
§ Patients ages 40-75 years and LDL-C ≥70 mg/dl and <190 mg/dl without 
diabetes: Use the risk estimator that best fits the patient and risk-enhancing 
factors to decide the intensity of statin needed. 
o Borderline Risk (5% to <7.5%): Risk discussion-- if risk-enhancing 
factors are present, discuss moderate-intensity statin and consider 
coronary CACs in select cases. 
o Intermediate Risk (≥7.5-20%): Risk discussion-- use moderate-intensity 
statins and increase to high-intensity with risk enhancers. Option of CACs 
to risk stratify if there is uncertainty about risk. If CAC = 0, can avoid 
statins and repeat CAC in the future (5-10 years), the exceptions being 
high-risk conditions such as diabetes, family history of premature CHD, 
and smoking. If CACs 1-100, it is reasonable to initiate moderate-
intensity statin for persons ≥55 years. If CAC >100 or 75th percentile or 
higher, use statin at any age. 
o High Risk (≥20%): Risk discussion to initiate high-intensity statin to 
reduce LDL-C by ≥50%. 
Tobacco 
Both tobacco use (including secondhand smoke) and smokeless tobacco are associated 
with increased ASCVD risk. It is estimated that 1/3 of CHD deaths are attributed to 
tobacco use. E-cigarettes are a tobacco delivery device that is growing in popularity, 
especially amongst youth and young adults. Because they are fairly new products, the 
long-term health risks are not certain. However, current research suggests that they 
contribute to cardiac and pulmonary disease. Case reports have also shown arrythmias 
and hypertension associated with e-cigarette use. All adults should be assessed for 
tobacco use at each visit and counseled on cessation if appropriate. Treatments include 
behavioral modification, nicotine replacement therapy or drug treatment with varenicline 





The ABCs of Primary Cardiovascular Prevention: 2019 Update.   




The development and progression of type 2 diabetes mellitus is heavily influenced by 
diet, physical activity, and body weight. The ACC/AHA recommends dietary counseling 
for a heart-healthy diet that lowers CVD events and CVD mortality, including the 
Mediterranean, DASH, and vegetarian/vegan diets in order to aid weight loss and 
glycemic control. It is estimated that at least 150 minutes/week of moderate to vigorous 
physical activity can lower HbA1c by 0.7%. The recommended first-line therapy in the 
treatment of diabetes to reduce CVD risk is metformin with a goal HbA1c of 6.5-7%. In 
comparison to lifestyle modifications, metformin has been shown to reduce micro- and 
macrovascular diabetes-related complications by 32% and reduce MIs by 39%. Other 
popular medications used for glycemic control, including sulfonylureas, do not 
demonstrate a reduction in ASCVD risk. However, SGLT-2 inhibitors and GLP-1R 
agonists have been shown to reduce ASCVD events and may be an appropriate addition 
to metformin for the prevention of ASCVD (Rubenfire, 2019).   
 
Diet, Weight & Exercise 
Dietary habits associated with increased risk of CVD mortality include sugar, low-
calorie sweeteners, high-carbohydrate diets, low-carbohydrate diets, refined grains, trans 
fat, saturated fat, sodium, red meat, and processed red meat (e.g. bacon, salami, ham, 
etc). A plant-based diet or Mediterranean-like diet is associated with a decrease in 
ASCVD and all-cause mortality. The ACC/AHA recommendation is for a diet high in 
vegetables, fruits, nuts, whole grains, lean vegetable or animal protein (preferably fish), 
and vegetable fiber. Diets focused on low carbohydrate intake and high intake of animal 
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fat and protein are associated with increased cardiac and non-cardiac mortality (Rubenfire, 
2019). 
 
A diagnosis of obesity can be made by a BMI ≥30 kg/m2 and a diagnosis of overweight 
by a BMI of 25-29.9 kg/m2. The ACC/AHA recommendation is for a low-calorie diet 
(500 calorie reduction) and high levels of physical activity (200-300 minutes/week). 
Clinically meaningful weight loss is defined as ≥5% initial weight and is associated with 
improvement in blood pressure, LDL-C, triglyceride, and glucose levels among obese or 
overweight individuals, and delays the development of type 2 diabetes mellitus (Rubenfire, 
2019). 
 
Adequate aerobic exercise is associated with decreased risk of ASCVD. The current 
recommendation from the ACC/AHA is for 150 minutes/week of moderate intensity or 




Health care providers 
should partner with 
patients who are women 
of color to empower them 
in doing their part to 
reduce the risk of 
cardiovascular disease. 
Here are some important 
education points and 
resources for reducing the 
risk and increasing 
knowledge and 
awareness in this patient population. 
 
Signs & Symptoms of Heart Attack Unique to Women 
Emphasize that women are more likely than men to experience anginal symptoms other 
than chest pain. Women are less likely to realize they are having a heart attack and 
therefore delay seeking care. Providers should educate women on the warning signs that 
they may be having a heart attack, including: 
§ Chest Tightness or Pressure 
§ Diaphoresis 
§ Shortness of Breath 
§ Fatigue or Lightheadedness 








Women of Color: Increasing Knowledge and Awareness 
The current literature reveals that women of color have a decreased knowledge and 
awareness of heart disease. Talk with your patients, especially women of color, about 
heart disease as women’s number one health threat. 
 
Here is some helpful information for patients on CVD as women’s number one 
health threat and how it disproportionately affects women of color in the 
United States: Cardiovascular Disease: Women's #1 Health Threat (American Heart 
Association, 2018)  
 
In addition to heart attack signs and symptoms unique to women, women of color 
should be aware of varying presentation impacted by race and ethnicity. A literature 
review by the American Heart Association (Graham et al., 2012) found that patients of racial 
and ethnic minorities presenting with CHD were more likely to be younger, be female 
and have other comorbidities such as diabetes, hypertension and obesity. Other key 
findings highlighted in this review include:  
§ In a study of elderly Black women with CHD, patients were more likely to 
experience unusual fatigue and sleep disturbance as prodromal symptoms, with 
less than half experiencing chest pain or discomfort. 
§ The most acute symptom in women of racial or ethnic minorities was found to be 
shortness of breath. 
§ In Hispanics undergoing coronary artery bypass graft surgery, patients are more 
likely to have more comorbidities, be female, be younger and have a lower BMI 
than others  
§ Chinese, South Asian and Southeast Asian patients were more likely to 
experience typical prodromal symptoms (i.e. chest pain or discomfort), however, 
were more likely to delay time to seeking emergency care.  
Read the review HERE  
 
 
Modifiable Risk Factors 
Educate your patients on everyday things they 
can do to actively take part in reducing their 
risk of cardiovascular disease.  
 
§ Talk about a heart healthy diet 
§ Counsel on weight loss if appropriate 
§ Encourage regular aerobic exercise 
§ Counsel on smoking and tobacco 
cessation if appropriate 










Helping Your Patients Monitor Blood Pressure 
African Americans have the highest incidence of hypertension in both men and women 
in the world. Emphasize that hypertension, often called “this silent killer”, usually does 
not have any symptoms until the damage has already been done.  
 
Point out measures that patients can take on a day-to-day basis to help lower blood 
pressure 
§ Eating a healthy diet, low in sodium—educate patients on reading nutrition labels 
and foods high in sodium (e.g. processed and packaged foods) 
§ Engaging in regular physical activity 
§ Maintaining a healthy weight 
§ Manage stress 
§ Limit alcohol intake 
§ Discuss medications, both OTC and prescription, used—many OTC medications, 
including commonly used decongestants and NSAIDs, can elevate blood pressure  
 
Patient blood pressure logs provided by the Washington State Department of Health—





How to check your blood pressure manually from the Washington State Department 
of Health (Washington State Department of Health, n.d.) 
 
English  
Spanish   
 
HERE is a link to the main page with more languages and additional resources for 
patients on monitoring their own blood pressure at home 
 
CULTURAL	CONSIDERATIONS	
Culture & CVD Risk 
Cultural beliefs and values influence patient’s understanding of health and illness. In 
fact, culture has been shown to have a greater impact on CVD risk and outcomes than 
genetics do (Graham et al., 2012). When partnering with patients to reduce risk, it is essential to 
assess how culture influences patient’s perceptions of CVD in order to promote 
meaningful change. However, limited studies exist on culture as it relates to women of 
color’s perceptions of heart health.  
 
State of the Science—Selected Literature 
§ A systematic review found that cultural beliefs surrounding health and illness 
contribute to the patient’s ability to understand and act on information and 
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instructions given by healthcare providers, indicating a need for provider 
assessment of cultural and language barriers and healthy literacy. (Shaw et al., 2008) 
 
§ A systematic review exploring how culture influences understanding of advanced 
heart failure found that symptoms were strongly related to cultural beliefs. 
Patients from Eastern and Middle Eastern cultures were found to somaticize 
symptoms more than patients of Western cultures. However, patients of Western 
cultures reported higher symptoms distress. Cultural beliefs impacted knowledge 
of heart failure diagnosis, cause, treatment, self-management and decisions about 
care and health behaviors. (Alassoud et al., 2020) 
 
§ A qualitative study revealed that African Americans were less likely to associate 
overweight and obesity and risk factors for CVD than other traditional risk 
factors (e.g. physical inactivity, poor diet, etc.). Participants of this study reported 
that they were open to modifying health behaviors if changes incorporated their 
input and were culturally acceptable. (Der Ananian et al., 2018) 
 
§ A mixed-methods study found that women of color, including Black, Latina and 
Asian American women, based their perceptions of CVD on past familial and 
cultural experiences, personal loss, personal sense of empowerment and 
complicated relationships with physicians. (Tindall & Vardeman-Winter, 2011) 
 
Assessing Your Patient’s Perception of Risk as it Relates to Culture 
 
(Image: https://www.meadowsranch.com/how-body-diversity-can-help-women-build-a-positive-body-image/)  
 
Assess cultural perceptions about body image—does the patient view themselves as 
overweight/obese or culturally normal? What does you patient and their culture view as 
overweight? (American Heart Association, 2019). 
 
Assess cultural beliefs about exercise—how useful is exercise for preventing disease? 
Are there cultural restrictions on the type and setting in which exercise may occur? (Chyun 
et al., 2003) 
 
Assess cultural beliefs about diet—what is this culture’s eating habits and dietary 
practices? What does the patient think is a healthy diet? What foods are important to 
their culture? (Chyun et al., 2003) 
 
Assess beliefs about smoking-- Is smoking or tobacco use a cultural norm? Are there 




Assess cultural perceptions of stress—how does the patient and their culture perceive 
stress? What are stressors for this 
population? Does racism or discrimination 
contribute to stress for this patient or her 





Social Determinants of Health & 
Barriers 
Socioeconomic inequalities are 
known determinants of 
cardiovascular health. It is 
recommended that providers consider social determinants of health when 
counseling patients on risk factor reduction strategies (American Heart Association, 2019).  
 
The main categories of social determinants of health, often intertwined, include: (Havranek et 
al., 2015) 
 
§ Socioeconomic Position 
§ Race and Ethnicity 
§ Social Support 
§ Culture and Language 
§ Access to Care 
§ Residential Environment 
 
Consider: 
Access— healthy foods, health care, financial resources, transportation to appointments 
 
Neighborhood Safety—may impact likelihood of engaging in physical activity 
 
Education and Language Barriers— this can heavily impact health literacy, the 
ability to understand or act on medical or therapeutic instructions. 
 
Cultural Norms—how does culture impact perception of risk? 
 
Family Support—does this patient have an adequate support system in place to achieve 




In sum, women of color are at an increased risk for CVD and decreased 
knowledge and awareness are doing them a disservice. I hope that you will 
use this toolbox as a resource and take special care to inform this patient 
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 Cardiovascular disease is the leading cause of death in women in the United States. 
Women of color (WOC) have a higher risk of CVD, paired with a decreased knowledge and 
understanding of CVD, compared to White women. In addition, healthcare providers are known 
to underestimate risk in this population, indicating a need for increased awareness amongst 
providers. Thus, the primary investigator of this scholarly project identified a need to close this 
gap in heart health knowledge between WOC and White women through enhanced provider to 
patient education in order to reduce further health disparity. A provider toolbox for CVD 
prevention in WOC in the primary care setting was therefore assembled and distributed to 
participants for clinic use. 
Participant Survey Results 
 The participant survey had a 50% response rate (n=4). Overall, participants rated the 
toolbox favorably. The quantitative data from the Likert-type items and fill in the blank item is 
described below with accompanying bar graphs indicating the frequency of responses and the 
median and mode. The qualitative data from the free response questions, which underwent 
content analysis for themes, is summarized below. 
Quantitative Data 
Sea Mar Monroe clinic sees a mean of 15.3 patients who are WOC for CVD weekly 
(Question 1), according to participants who responded to this question (n=3). All participants 
(n=4) strongly agreed that the toolbox informed their knowledge on WOC and CVD (see Figure 
1). 50% of participants strongly agreed that they felt better equipped to address this clinical 
practice issue after viewing the toolbox and its presentation, and the other 50% of participants 
somewhat agreed (see Figure 2). All participants strongly agreed that the toolbox will enable 
them to optimize cardiovascular care of WOC at risk for CVD (see Figure 3). All participants 
strongly agreed that the toolbox resource will help them facilitate evidence-based practice in 
their practice setting (see Figure 4).  
The median and mode were analyzed to determine central tendency of responses. The 
scale for the responses ranged from numbers 1 through 5, with 1= strongly disagree and 5= 
strongly agree. Based on this information, it can be determined that the central tendency of 
responses was consistent with “strongly agree” for all questions except question three, which 
ranged from “agree” to “strongly agree” (see Table 1). 
Qualitative Data 
The common themes identified were conceptualizing race as a specific risk factor, time as 
a barrier for both providers and WOC, and money and lack of prioritization as barriers for WOC.  
Race as a Specific Risk Factor. Participants indicated that the toolbox helped reinforce 
their knowledge of race as a specific risk factor for CVD. One respondent indicated that 
providers often approach patients in an algorithmic fashion when considering risk factors, and 
race is often overlooked. 
Time & Money. Time was an overarching theme related to barriers for CVD prevention 
for both providers and WOC. Participants wrote that short appointment times inhibited them 
from being able to provide adequate CVD education to patients. Additionally, lack of time was 
identified as a barrier for WOC to seek preventative care or make follow up appointments.  
Lack of Prioritization. Another theme was family prioritization. Participants described 
WOC patients as mothers, spouses and full-time workers, making them more likely to put their 
own health “on the back burner” and prioritize family needs above their own. 
Implications for Future Practice 
The information and resources in the toolbox served as a useful resource in both 
increasing provider awareness of this health disparity and educating WOC patients on CVD. In 
the long term, it is predicted that use of this toolbox will improve health outcomes in this patient 
population if toolbox use is continued. Participants should note that practice guidelines will need 
to be periodically reviewed and changes made to the toolbox as indicated. 
Time was found to be a barrier for both providers and patients. Providers expressed 
difficulty providing in-depth education on CVD prevention due to short appointment times, and 
providers reported that patients are often unable or unwilling to take the time for preventative 
care and follow up. A potential solution to this dilemma would be to include alternate forms of 
CVD education in addition to typical provider-to-patient verbal education. Providers may use 
EPIC’s patient education materials on CVD and attach it to the after-visit summary. This has the 
potential to increase patient education in a manner that is time-sparing for both patients and 
providers. Additionally, providers may take advantage of referring WOC at risk for CVD to the 
clinic health educator or nutritionist for further counseling.  
Additionally, this toolbox has the potential to be used in other practice settings where 
primary and preventative care is delivered. With the exception of health indicators specific to 
Snohomish County, the toolbox is generalizable to a national audience, and Sea Mar Monroe 





















Note. “I anticipate that the toolbox resources will help me to facilitate evidence-based practice in 
my practice setting.” 
 
Table 1 
Median and Mode of Likert-type Item Responses 
Variable Median Mode 
Question 2 5 5 
Question 3 4.5 4, 5 
Question 4 5 5 
Question 5 5 5 
 
 
Appendix C: Participant Survey 
Approximately how many patients who are women of color do you see (have an appointment 
with) on a weekly basis? 
 
































How has this toolbox impacted your approach to care of patients who are women of color at risk 
for CVD? Please explain. 
 
 




What barriers do you believe providers face in providing CVD education to patients? Please 
explain. 
 
What barriers do you believe patients who are women of color face in taking action to reduce 
their risk of CVD? Please explain.  
 
 
